Michael Gelband’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Michael Gelband’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24,300	Closed	-$18K	–	2353
2023 Q1	$18K	Buy	+24,300	New	+$17.7K	﹤0.01%	1693
2022 Q1	–	Sell	-168,847	Closed	-$214K	–	2801
2021 Q4	$214K	Buy	168,847 +106,694	+172%	+$191K	﹤0.01%	1801
2021 Q3	$135K	Buy	+62,153	New	+$170K	﹤0.01%	1861
2021 Q1	–	Sell	-24,653	Closed	-$84K	–	2739
2020 Q4	$84K	Buy	24,653 +10,750	+77%	+$44.2K	﹤0.01%	1851
2020 Q3	$57K	Sell	13,903 -6,255	-31%	-$23.8K	﹤0.01%	1629
2020 Q2	$68K	Buy	+20,158	New	+$58.7K	﹤0.01%	1665
2020 Q1	–	Sell	-34,200	Closed	-$124K	–	1786
2019 Q4	$124K	Buy	34,200 +23,500	+220%	+$190K	﹤0.01%	1409
2019 Q3	$89K	Buy	+10,700	New	+$86.6K	﹤0.01%	1247

Other funds holding SPPI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Michael Gelband's SPPI Position: Q2 2023 in Review

Michael Gelband sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 24,300 shares — an estimated $18K sold.

Michael Gelband first reported a position in SPPI in Q3 2019 and held it in 8 quarters. The position peaked at $214K in Q4 2021. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

Michael Gelband reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
Michael Gelband sold 24,300 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $18K.
Michael Gelband first reported a position in Spectrum Pharmaceuticals Inc in Q3 2019 and held it in 8 quarters.
Michael Gelband's Spectrum Pharmaceuticals Inc position peaked at $214K in Q4 2021.
78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.